BPN14770
99%
- Product Code: 151197
CAS:
1606974-33-7
Molecular Weight: | 405.80 g./mol | Molecular Formula: | C₂₁H₁₅ClF₃NO₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C |
Product Description:
Used in research for neurodegenerative disorders, particularly Alzheimer’s disease. Shows potential in improving cognitive function by modulating synaptic plasticity and enhancing memory. Acts as a selective inhibitor of phosphodiesterase-4D (PDE4D), which plays a role in regulating cyclic AMP levels in brain cells. This mechanism supports neuronal communication and may slow cognitive decline. Investigated for therapeutic use in fragile X syndrome due to its impact on learning and memory pathways. Currently in experimental stages, primarily in preclinical and early clinical trials.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
1mg | 10-20 days | ฿10,080.00 |
+
-
|
5mg | 10-20 days | ฿20,800.00 |
+
-
|
BPN14770
Used in research for neurodegenerative disorders, particularly Alzheimer’s disease. Shows potential in improving cognitive function by modulating synaptic plasticity and enhancing memory. Acts as a selective inhibitor of phosphodiesterase-4D (PDE4D), which plays a role in regulating cyclic AMP levels in brain cells. This mechanism supports neuronal communication and may slow cognitive decline. Investigated for therapeutic use in fragile X syndrome due to its impact on learning and memory pathways. Currently in experimental stages, primarily in preclinical and early clinical trials.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :